Biohaven Ltd (NYSE:BHVN)
| 21.71 Delayed Data As of Jun 02 |  +0.98 / +4.73%Today’s Change | 5.54 Today|||52-Week Range 22.05 | +56.41% Year-to-Date |
Latest BHVN News | Press Releases
| Why Biohaven Stock Caught Fire This Week Jun 02 / MotleyFool.com - Paid Partner Content | Biohaven (BHVN) Stock up 8% on Encouraging Pipeline Updates Jun 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 20.73 |
| Today’s open | 21.13 |
| Day’s range | 20.10 - 22.03 |
| Volume | 2,045,530 |
| Average volume (3 months) | 949,615 |
| Market cap | $1.5B |
Data as of 4:00pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -151.82% |
| Earnings growth (this year) | +63.91% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.75 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 30, 2023 |
| EPS forecast (this quarter) | -$1.18 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$570.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
